Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Good financial results growth rate 98.6% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (2.1%)
  • Dividend yield for the last twelve months 6.8%
  • Free cash flow yield 9.8% (LTM)
  • Share price is 16.1% higher than minimum and 54.0% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (10.9x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: PFE
Share price, USD:  (-0.7%)25.0677
year average price 25.24  


year start price 29.16 2024-10-11

max close price 29.67 2024-10-16

min close price 21.59 2025-04-10

current price 25.07 2025-10-10
Common stocks: 5 615 000 000

Dividend Yield:  6.8%
FCF Yield LTM: 9.8%
EV / LTM EBITDA: 10.9x
EV / EBITDA annualized: 10.2x
Last revenue growth (y/y):  +10.3%
Last growth of EBITDA (y/y):  +186.8%
Historical revenue growth:  -10.3%
Historical growth of EBITDA:  +14.6%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 140 755
Net Debt ($m): 48 865
EV (Enterprise Value): 189 620
EBITDA LTM ($m): 17 323
EV / LTM EBITDA: 10.9x
Price to Book: 1.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-10-10fool.com

Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors?

2025-10-08zacks.com

3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal

2025-10-07zacks.com

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? (Revised)

2025-10-07fool.com

Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500

2025-10-07seekingalpha.com

Pfizer Offers High Yield And Capital Appreciation Opportunities (Technical Analysis)

2025-10-06marketbeat.com

Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal

2025-10-06zacks.com

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

2025-10-05fool.com

Can Pfizer's Stock Break This Disappointing Streak?

2025-10-04247wallst.com

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (October 2025)

2025-10-03zacks.com

Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump?
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data